NCT01324011

Brief Summary

NOTE: This study is in the trial-phase of a 5-year study that included a formative research phase (Phase 1 - IRB study # 07-1765 "Family-based Diabetes Self-management Training for African American Adults"). During the first phase, eight focus groups were conducted with 68 participants and a validation study with 215 African American patients with type 2 diabetes. The data gathered in Phase 1 informs the refinement of the intervention in this phase. Purpose: The overall goal of this research is to evaluate, in a randomized controlled trial, a family-based diabetes self-management intervention for overweight/obese African American adults with type 2 diabetes (the "index participants") and a paired overweight family member (co-participant) who does not have diabetes. The primary outcome is weight change in the index participant.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
108

participants targeted

Target at P50-P75 for not_applicable diabetes-mellitus

Timeline
Completed

Started Jan 2011

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2011

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

March 24, 2011

Completed
4 days until next milestone

First Posted

Study publicly available on registry

March 28, 2011

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2012

Completed
Last Updated

July 17, 2013

Status Verified

July 1, 2013

Enrollment Period

1.7 years

First QC Date

March 24, 2011

Last Update Submit

July 15, 2013

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in body weight

    Change in weight from start to end of the 20-weekly group-based intervention. NOTE: Weekly sessions are not held during weeks where holidays occur on a scheduled session date (such that the duration of the intervention may be more than 20 weeks).

    6 months

Secondary Outcomes (4)

  • Effect on Hemoglobin A1c

    6 months (post-intervention)

  • Lifestyle behaviors

    6 months

  • Blood pressure change

    6 months

  • Change in psychosocial factors

    6 months

Study Arms (2)

Family-based intervention

EXPERIMENTAL

Special intervention (20 weekly group-based sessions) to be compared with a delayed intervention control group.

Behavioral: Adult diabetes family-based weight loss intervention

Delayed intervention controls

OTHER

The delayed intervention controls will continue with usual care (if patients with diabetes)and at the end of the experimental period (6 months), they will receive a 6-session weight loss intervention delivered over a 2 month period.

Behavioral: Adult diabetes family-based weight loss intervention

Interventions

Participants assigned to the experimental group will begin the 2o-week weight loss intervention, while delayed intervention controls will wait until the end of this period to begin their program. The weight loss intervention includes 20 weekly group-based sessions facilitated by a registered dietitian. Each group session will last about 120 minutes and include: weight check, group sharing and problem-solving, discussion of a weight control topics (nutrition, physical activity, or behavior change), physical activity and/or taste-testing. Ten sessions will include a brief component, focused on improving family relationships for better diabetes self-care. The study weight loss goal is ≥10 pounds (minimum rate-0.5 lb/week; maximum-2 lbs/week). While the control group waits, they will receive 1 newsletter with study updates and general health or diabetes information. The delayed intervention includes 6 sessions (4 weekly + 2 bi-weekly) following the same format as the experimental group.

Also known as: intense weight loss intervention, family-based lifestyle intervention
Delayed intervention controlsFamily-based intervention

Eligibility Criteria

Age21 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • self-described African American 21-75 years of age;
  • self-reported diagnosis of type 2 diabetes;
  • A1c value ≤ 11%;
  • currently under the care of a physician or other health care provider;
  • able to participate in moderate level physical activity;
  • willing to lose 5% or more of initial body weight and follow recommendations for healthy dietary and physical activity patterns;
  • access to a phone and willing to complete a telephone-administered survey;
  • English speaking.

You may not qualify if:

  • any medical contraindication to weight loss;
  • cardiovascular event within the past 6 months;
  • evidence of active cancer diagnosis;
  • pregnant or lactating;
  • self-reported history of renal disease other than kidney stones;
  • any history of gastric bypass surgery or scheduled surgery for this purpose;
  • weight loss of \>20 lbs in the last 3 months;
  • current use of medications for weight loss, treatment of psychosis or manic-depressive illness.
  • years of age;
  • living with or married (for at least 1 year) to an African American adult diagnosed with diabetes;
  • self-described as a blood relative of an African American with diabetes with whom there is regular, ongoing contact;
  • overweight/obesity defined as a BMI between 25 to 47, inclusive;
  • English-speaking;
  • able to participate in moderate level physical activity;
  • willing to lose 5% or more of initial body weight and follow recommendations for healthy dietary and physical activity patterns;
  • +11 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UNC Center for Health Promotion and Disease Prevention (HPDP)

Chapel Hill, North Carolina, 27599-7426, United States

Location

MeSH Terms

Conditions

Diabetes Mellitus

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Officials

  • Carmen D. Samuel-Hodge, PhD

    University of North Carolina, Chapel Hill

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Assistant Professor

Study Record Dates

First Submitted

March 24, 2011

First Posted

March 28, 2011

Study Start

January 1, 2011

Primary Completion

September 1, 2012

Study Completion

September 1, 2012

Last Updated

July 17, 2013

Record last verified: 2013-07

Locations